| scholarly article | Q13442814 |
| P356 | DOI | 10.1212/WNL.61.3.316 |
| P698 | PubMed publication ID | 12913190 |
| P50 | author | John H. J. Wokke | Q110189996 |
| P2093 | author name string | Burger H | |
| van Venrooij WJ | |||
| Dinant HJ | |||
| Voskuyl AE | |||
| Hoogendijk JE | |||
| Linssen WH | |||
| de Visser M | |||
| Bronner IM | |||
| van der Meulen MF | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | polymyositis | Q980926 |
| P304 | page(s) | 316-321 | |
| P577 | publication date | 2003-08-01 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | Polymyositis: an overdiagnosed entity | |
| P478 | volume | 61 |
| Q47653276 | 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups |
| Q47699498 | 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. |
| Q42365042 | 213th ENMC International Workshop: Outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18-20 September 2015 |
| Q36020670 | A case report of autoimmune necrotizing myositis presenting as dysphagia and neck swelling |
| Q58608047 | A pattern-based approach to the interpretation of skeletal muscle biopsies |
| Q35108174 | Altered lipid levels in untreated patients with early polymyositis |
| Q38314711 | Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken. |
| Q35915184 | Amyloid myopathy: characteristic features of a still underdiagnosed disease |
| Q30249874 | Amyopathic Dermatomyositis: A Concise Review of Clinical Manifestations and Associated Malignancies |
| Q34667765 | An overview of polymyositis and dermatomyositis |
| Q37613347 | Atorvastatin-induced necrotizing autoimmune myositis: An emerging dominant entity in patients with autoimmune myositis presenting with a pure polymyositis phenotype |
| Q26744554 | Autoimmune Myopathies: Where Do We Stand? |
| Q27306863 | Beneficial role of rapamycin in experimental autoimmune myositis |
| Q83216556 | Brachio-cervical inflammatory myopathies: clinical, immune, and myopathologic features |
| Q84985997 | CD8/MHC-I Complex is Specific but Not Sensitive for the Diagnosis of Polymyositis |
| Q91059371 | Classification and management of adult inflammatory myopathies |
| Q52590882 | Classification of myositis. |
| Q38133017 | Clinical aspects of autoimmune rheumatic diseases |
| Q51527887 | Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy. |
| Q34495766 | Clinical, electrophysiologic, and histopathologic profile, and outcome in idiopathic inflammatory myositis: An analysis of 68 cases |
| Q37726608 | Correlation of clinicoserologic and pathologic classifications of inflammatory myopathies: study of 178 cases and guidelines for diagnosis |
| Q54977148 | Current Classification and Management of Inflammatory Myopathies. |
| Q45838048 | Cutaneous ulceration: more than skin deep? |
| Q48539566 | Cytokine Profiling of Serum Allows Monitoring of Disease Progression in Inclusion Body Myositis. |
| Q50691094 | Detection of the membrane attack complex as a diagnostic tool in dermatomyositis. |
| Q57612622 | Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies |
| Q30249522 | Diagnosis and classification of idiopathic inflammatory myopathies |
| Q92905249 | Diagnostic value of additional histopathological fascia examination in idiopathic inflammatory myopathies |
| Q36562003 | Differential diagnosis of idiopathic inflammatory myopathies |
| Q57245349 | EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report |
| Q53375302 | Editorial: A New Classification of Adult Autoimmune Myositis. |
| Q44914388 | Efficacy of tacrolimus in treatment of polymyositis associated with myasthenia gravis |
| Q46107385 | Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan |
| Q36602766 | Epidemiology of neuroimmunological diseases |
| Q37691061 | Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies. |
| Q36142434 | Expression of granulysin in polymyositis and inclusion-body myositis |
| Q35615121 | Genes, trials, and care: the dynamics of neuromuscular disease |
| Q51540185 | Guidelines on dermatomyositis--excerpt from the interdisciplinary S2k guidelines on myositis syndromes by the German Society of Neurology. |
| Q36098608 | Health-Related Quality of Life (HRQoL) in Idiopathic Inflammatory Myopathy: A Systematic Review |
| Q33293736 | Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes |
| Q26744705 | Idiopathic Inflammatory Myopathies: Clinical Approach and Management |
| Q27025125 | Idiopathic inflammatory myopathies |
| Q37674765 | Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review |
| Q33924451 | Idiopathic inflammatory myopathies. |
| Q35580539 | Idiopathic inflammatory myopathies: A treatment update |
| Q36067720 | Imaging and skeletal muscle disease |
| Q33753870 | Immune and myodegenerative pathomechanisms in inclusion body myositis |
| Q38131966 | Incidence and prevalence of idiopathic inflammatory myopathies in South Australia: a 30-year epidemiologic study of histology-proven cases |
| Q26999366 | Incidence and prevalence of inflammatory myopathies: a systematic review |
| Q82029903 | Inclusion body myositis |
| Q92150187 | Inclusion body myositis: clinical features and pathogenesis |
| Q42655964 | Increased prevalence of celiac disease in idiopathic inflammatory myopathies. |
| Q28083759 | Inflammation induced loss of skeletal muscle |
| Q61455247 | Inflammatory myopathy with myasthenia gravis: Thymoma association and polymyositis pathology |
| Q39027323 | Integrated classification of inflammatory myopathies |
| Q34662975 | Is statin-induced myositis part of the polymyositis disease spectrum? |
| Q87497065 | Long-term follow-up of 62 patients with myositis |
| Q35638147 | Long-term outcome in polymyositis and dermatomyositis |
| Q37414099 | Malignancy is associated with dermatomyositis but not polymyositis in Northern New England, USA. |
| Q28277040 | Myopathy associated with gluten sensitivity |
| Q36562015 | Myositis specific autoantibodies |
| Q36364785 | Myositis-specific autoantibodies are specific for myositis compared to genetic muscle disease. |
| Q37788945 | Neurologists are from Mars. Rheumatologists are from Venus: differences in approach to classifying the idiopathic inflammatory myopathies |
| Q38215698 | Neurology of rheumatologic disorders |
| Q55277507 | New Myositis Classification Criteria-What We Have Learned Since Bohan and Peter. |
| Q36174530 | Paediatric idiopathic inflammatory muscle disease: recognition and management. |
| Q41649938 | Paraneoplastic Necrotizing Autoimmune Myopathy in a Patient Undergoing Laparoscopic Pancreatoduodenectomy for Distal Cholangiocarcinoma |
| Q37790632 | Polymyositis associated with hypothyroidism or hyperthyroidism: two cases and review of the literature |
| Q41577325 | Polymyositis, a very uncommon isolated disease: clinical and histological re-evaluation after long-term follow-up |
| Q34377234 | Polymyositis, invasion of non-necrotic muscle fibres, and the art of repetition |
| Q37704799 | Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis |
| Q36461742 | Prognosis of polymyositis and dermatomyositis. |
| Q34644962 | Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial |
| Q37150812 | Role of regulatory T cells in a new mouse model of experimental autoimmune myositis |
| Q41240470 | SLE myopathy: a clinicopathological study |
| Q36132166 | Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART). |
| Q37570702 | The Correlation of Muscle Biopsy Scores with the Clinical Variables in Idiopathic Inflammatory Myopathies |
| Q27014908 | The importance of including amyopathic dermatomyositis in the idiopathic inflammatory myositis spectrum |
| Q64998657 | The performance of the European League Against Rheumatism/American College of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohort. |
| Q58099249 | Whole-body MRI and pathological findings in adult patients with myopathies |
| Q84600671 | [Inflammatory myopathies. Dermatomyositis, polymyositis, and inclusion body myositis] |
| Q82421976 | [Muscular complications of human immunodeficiency virus (HIV) infection in the era of effective anti-retroviral therapy] |
| Q54258621 | [Myositides: What is the current situation?]. |
| Q80257893 | [Use of i.v. immunoglobulins in neurology. Evidence-based consensus] |
Search more.